NLR: a cost-effective nomogram to guide therapeutic interventions in COVID-19
KE Kerboua - Immunological Investigations, 2021 - Taylor & Francis
ABSTRACT COVID-19 exhibits a non-yet elucidated heterogeneity dominated by mild form
of the illness. Nevertheless, mortality is frequent among patients with a delayed innate …
of the illness. Nevertheless, mortality is frequent among patients with a delayed innate …
NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19
KE Kerboua - Immunological investigations, 2021 - pubmed.ncbi.nlm.nih.gov
COVID-19 exhibits a non-yet elucidated heterogeneity dominated by mild form of the illness.
Nevertheless, mortality is frequent among patients with a delayed innate immune response …
Nevertheless, mortality is frequent among patients with a delayed innate immune response …
NLR: a cost-effective nomogram to guide therapeutic interventions in COVID-19.
KE Kerboua - 2021 - cabidigitallibrary.org
COVID-19 exhibits a non-yet elucidated heterogeneity dominated by mild form of the illness.
Nevertheless, mortality is frequent among patients with a delayed innate immune response …
Nevertheless, mortality is frequent among patients with a delayed innate immune response …
[引用][C] NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19
KE Kerboua - Immunological Investigations, 2020 - cir.nii.ac.jp
NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19.
KE Kerboua - Immunological Investigations, 2020 - europepmc.org
COVID-19 exhibits a non-yet elucidated heterogeneity dominated by mild form of the illness.
Nevertheless, mortality is frequent among patients with a delayed innate immune response …
Nevertheless, mortality is frequent among patients with a delayed innate immune response …